A citation-based method for searching scientific literature


List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis,[...]. Lancet 2018
147
66


Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus.
Per Eriksson, Philip Wallin, Christopher Sjöwall. Front Pharmacol 2019
19
50

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
David Fernandez, Eduardo Bonilla, Naureen Mirza, Brian Niland, Andras Perl. Arthritis Rheum 2006
200
50


Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.
Desmond Y H Yap, Colin Tang, Gary C W Chan, Lorraine P Y Kwan, Maggie K M Ma, Maggie M Y Mok, Tak Mao Chan. J Rheumatol 2018
22
33


Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Karen L Bride, Tiffaney Vincent, Kim Smith-Whitley, Michele P Lambert, Jack J Bleesing, Alix E Seif, Catherine S Manno, James Casper, Stephan A Grupp, David T Teachey. Blood 2016
93
33

Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
David R Fernandez, Tiffany Telarico, Eduardo Bonilla, Qing Li, Sanjay Banerjee, Frank A Middleton, Paul E Phillips, Mary K Crow, Stefanie Oess, Werner Muller-Esterl,[...]. J Immunol 2009
148
33

Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
33

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
Zachary Oaks, Thomas Winans, Nick Huang, Katalin Banki, Andras Perl. Curr Rheumatol Rep 2016
42
33


Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway.
Jingjing He, Jun Ma, Bingrui Ren, Aijing Liu. Semin Arthritis Rheum 2020
8
33

The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.
John P Ray, Matthew M Staron, Justin A Shyer, Ping-Chih Ho, Heather D Marshall, Simon M Gray, Brian J Laidlaw, Koichi Araki, Rafi Ahmed, Susan M Kaech,[...]. Immunity 2015
167
33


Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
Takayuki Katsuyama, George C Tsokos, Vaishali R Moulton. Front Immunol 2018
70
33


Immunometabolism in systemic lupus erythematosus.
Laurence Morel. Nat Rev Rheumatol 2017
96
33

Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
Taisuke Ito, Masahiro Aoshima, Natsuho Ito, Izumi Uchiyama, Keiko Sakamoto, Tetsuya Kawamura, Hiroaki Yagi, Hideo Hashizume, Masahiro Takigawa. Arch Dermatol Res 2009
17
16

Comparison of interleukin-17- producing cells in different clinical types of alopecia areata.
Genichi Tojo, Taku Fujimura, Mitsuko Kawano, Kouetsu Ogasawara, Yumi Kambayashi, Sadanori Furudate, Masato Mizuashi, Setsuya Aiba. Dermatology 2013
26
16

Acute alopecia totalis.
Hye-Ja Choi, Chull-Wan Ihm. Acta Dermatovenerol Alp Pannonica Adriat 2006
9
16

Trichoscopy of alopecia areata: An update.
Anna Waśkiel, Adriana Rakowska, Mariusz Sikora, Małgorzata Olszewska, Lidia Rudnicka. J Dermatol 2018
17
16

Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
Lauren C Strazzulla, Eddy Hsi Chun Wang, Lorena Avila, Kristen Lo Sicco, Nooshin Brinster, Angela M Christiano, Jerry Shapiro. J Am Acad Dermatol 2018
97
16


Acute diffuse and total alopecia of the female scalp albeit on immunossupression.
Karina Lopes Morais, Alessandra Anzai, Neusa Yuriko Sakai Valente, Ricardo Romiti. Int J Trichology 2017
1
100


Factors Associated with Severity of Alopecia Areata.
Hye Rin You, Seong-Jin Kim. Ann Dermatol 2017
16
16

From telogen to exogen: mechanisms underlying formation and subsequent loss of the hair club fiber.
Claire A Higgins, Gillian E Westgate, Colin A B Jahoda. J Invest Dermatol 2009
50
16


Acute diffuse and total alopecia of the female scalp associated with borrelia-infection.
Ekta K Bhardwaj, Ralph Michel Trüeb. Int J Trichology 2015
3
33

Clinical significance of dermoscopy in alopecia areata: analysis of 300 cases.
Shigeki Inui, Takeshi Nakajima, Koichi Nakagawa, Satoshi Itami. Int J Dermatol 2008
118
16

Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata.
Masaki Uchiyama, Chizu Egusa, Ayako Hobo, Ryokichi Irisawa, Masashi Yamazaki, Ryoji Tsuboi. J Am Acad Dermatol 2012
20
16

Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis.
Bark-Lynn Lew, Min-Kyung Shin, Woo-Young Sim. J Am Acad Dermatol 2009
34
16

Biomarkers of alopecia areata disease activity and response to corticosteroid treatment.
Judilyn Fuentes-Duculan, Nicholas Gulati, Kathleen M Bonifacio, Norma Kunjravia, Xiuzhong Zheng, Mayte Suárez-Fariñas, Avner Shemer, Emma Guttman-Yassky, James G Krueger. Exp Dermatol 2016
36
16


The epidemiology of childhood alopecia areata in China: a study of 226 patients.
Feng-Li Xiao, Sen Yang, Jiang-Bo Liu, Ping-Ping He, Jie Yang, Yong Cui, Kai-Lin Yan, Min Gao, Yan-Hua Liang, Xue-Jun Zhang. Pediatr Dermatol 2006
46
16

Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.
Elizabeth L Yanik, Kulsoom Siddiqui, Eric A Engels. Cancer Med 2015
60
16



Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
16

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
S Bernatsky, L Joseph, J-F Boivin, C Gordon, M Urowitz, D Gladman, P R Fortin, E Ginzler, S-C Bae, S Barr,[...]. Ann Rheum Dis 2008
100
16



Is sirolimus a treatment option for patients with systemic lupus erythematosus?
Sinem Nihal Esatoglu, Emire Seyahi. Clin Exp Rheumatol 2019
1
100


Rapamycin for refractory discoid lupus erythematosus.
Mitchell Herold, Nicholas A Richmond, Michael A Montuno, Stanton K Wesson, Kiran Motaparthi. Dermatol Ther 2018
8
16

Rapamycin: one drug, many effects.
Jing Li, Sang Gyun Kim, John Blenis. Cell Metab 2014
487
16

Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Guillaume Canaud, Frank Bienaimé, Fanny Tabarin, Guillaume Bataillon, Danielle Seilhean, Laure-Hélène Noël, Marie-Agnès Dragon-Durey, Renaud Snanoudj, Gérard Friedlander, Lise Halbwachs-Mecarelli,[...]. N Engl J Med 2014
168
16

Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis.
Chenzhu Zhang, Caleb C Y Chan, Kwok Fan Cheung, Mel K M Chau, Desmond Y H Yap, Maggie K M Ma, Kwok Wah Chan, Susan Yung, Tak Mao Chan. Clin Sci (Lond) 2019
6
16

The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis.
Faith Matcham, Lauren Rayner, Sophia Steer, Matthew Hotopf. Rheumatology (Oxford) 2013
337
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.